The lean pharma business collaborates with top university scientists and medical oncologists to create products through a network of established research organizations. Their technology aims to improve patient outcomes and care for those with pancreatic cancer, bile duct cancer, and relapsed metastatic disease, as many patients show little response to standard immunotherapy or chemotherapy. Duo Oncology plans to transform patient outcomes with a new type of nanotherapy.